1 Min Read
Oct 4 (Reuters) - Genentech:
* FDA APPROVES GENENTECH’S HEMLIBRA (EMICIZUMAB-KXWH) FOR HEMOPHILIA A WITHOUT FACTOR VIII INHIBITORS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.